Key Takeaways
- • Peter Thiel, with an estimated net worth of $8.13 billion (Bloomberg Billionaires Index), confirmed he is signed up for cryogenic preservation through biotech firm Alcor, though he expresses skepticism about the technology's efficacy.
- • Thiel frames his cryonics enrollment as an "ideological statement" rather than a conviction-based decision, stating he does not expect the procedure to work but believes it represents a worthwhile scientific pursuit.
- • The billionaire has declined to enroll family members in cryonic preservation, citing insufficient confidence in the technology: "I'm not convinced it works. It's more, I think we need to be trying these things."
- • Thiel's interest in life-extension and anti-aging technologies aligns with a broader billionaire cohort—including Sam Altman, Jeff Bezos, and Larry Ellison—who are allocating capital toward mortality-disruption ventures.
- • The confirmation emerged during a podcast interview with journalist Bari Weiss, where Thiel also signaled support for Ron DeSantis in the 2024 GOP presidential race.
Summary
Peter Thiel, the PayPal co-founder and venture capital pioneer with a reported $8.13 billion net worth, reiterated his enrollment in a cryogenic preservation program during a May 2023 podcast appearance with journalist Bari Weiss. When asked directly whether he is signed up to be frozen after death for potential future revival, Thiel confirmed the arrangement while simultaneously expressing fundamental doubt about its viability.
Thiel's framing of the decision is notably pragmatic and detached from expectation of success. He characterized his cryonics enrollment as "more of an ideological statement" than a conviction-backed bet, stating plainly: "I don't necessarily expect it to work, but I think it's the sort of thing we're supposed to try to do." This distinction—between participation as principle and belief in outcome—underscores Thiel's positioning of cryonics within a broader portfolio of speculative, high-risk ventures worth pursuing despite uncertain payoff.
When pressed on whether he has extended the arrangement to family members, Thiel explicitly distanced loved ones from the decision, reaffirming his skepticism: "I'm not convinced it works." His rationale centers on the philosophical necessity of experimentation rather than personal confidence in technology maturation. Thiel first publicly disclosed his cryonics enrollment in 2014 through The Telegraph, revealing his partnership with Alcor, a biotech firm specializing in cryogenic preservation services.
Thiel's sustained interest in life-extension technologies positions him alongside other high-net-worth investors—including OpenAI's Sam Altman, Amazon founder Jeff Bezos, and Oracle's Larry Ellison—who have collectively allocated hundreds of millions into startups targeting human mortality and aging. The confirmation arrives as Thiel continues his involvement in venture capital and political influence, with the same podcast conversation touching on his planned support for Florida Governor Ron DeSantis in the 2024 Republican presidential primary.
Thiel's framing of the decision is notably pragmatic and detached from expectation of success. He characterized his cryonics enrollment as "more of an ideological statement" than a conviction-backed bet, stating plainly: "I don't necessarily expect it to work, but I think it's the sort of thing we're supposed to try to do." This distinction—between participation as principle and belief in outcome—underscores Thiel's positioning of cryonics within a broader portfolio of speculative, high-risk ventures worth pursuing despite uncertain payoff.
When pressed on whether he has extended the arrangement to family members, Thiel explicitly distanced loved ones from the decision, reaffirming his skepticism: "I'm not convinced it works." His rationale centers on the philosophical necessity of experimentation rather than personal confidence in technology maturation. Thiel first publicly disclosed his cryonics enrollment in 2014 through The Telegraph, revealing his partnership with Alcor, a biotech firm specializing in cryogenic preservation services.
Thiel's sustained interest in life-extension technologies positions him alongside other high-net-worth investors—including OpenAI's Sam Altman, Amazon founder Jeff Bezos, and Oracle's Larry Ellison—who have collectively allocated hundreds of millions into startups targeting human mortality and aging. The confirmation arrives as Thiel continues his involvement in venture capital and political influence, with the same podcast conversation touching on his planned support for Florida Governor Ron DeSantis in the 2024 Republican presidential primary.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.